Skip to main content
. 2023 Apr 11;13(4):665. doi: 10.3390/biom13040665

Table 1.

Characteristics of the included studies.

Study, Year [Ref.] Study Design N° of Patients Population Control Group MMP Other Factos Outcomes Main Findings
Bradham, 2002 [10] Prospective observational NRCT 51 Patient with HOCM submitted to alcohol septal ablation (51 pts) - MMP-2, MMP-8, MMP-9, MMP-13, TIMP-1 CK
CK-MB1
  • To analyse the temporal profile of MMPs plasma levels after alcohol-induced MI;

  • To evaluate the relationship between alcohol-induced MI and MMPs plasma levels.

  • MMP-2 increased at 4 h post alcohol injection.

  • MMP-8 increased by 6 h post injection and remained elevated for up to 60 h post injection.

  • MMP-9 increased at 6 h and remained elevated for up to 50 h post injection.

  • MMP-13 decreased at 24 h post injection.

  • TIMP-1 increased at late time points post alcohol injection but without statistical significance.

  • MMP-8/TIMP-1 and MMP-9/TIMP-1 ratios increased post alcohol septal ablation.

Lombardi, 2003 [11] Prospective observational NRCT 50 Patient with HOCM (36 pts) Healthy subjects (14 pts) MMP-1, MMP-2, MMP-9, TIMP-1 ICTP, PICP, PINP
  • To evaluate myocardial collagen turnover;

  • To assess myocardial collagen turnover on diastolic function.

  • HOCM patients had higher MMPs plasma levels than the control group.

  • No correlation between biomarkers of collagen turnover and severity of left ventricular hypertrophy.

Fassbach, 2004 [12] Prospective observational NRCT 64 Patient with HOCM (26 pts) Healthy subjects (38 pts) MMP-1, TIMP-1 ICTP, PICP
  • To evaluate myocardial collagen turnover;

  • To assess myocardial collagen turnover on diastolic function.

  • TIMP-1 was elevated in HOCM patients.

  • MMP-1 was higher in HOCM patients.

  • MMP-1/TIMP-1 ratio was lower in HOCM patients.

Noji, 2004 [13] Prospective observational NRCT 78 Patient with HOCM (28 pts) Healthy subjects (50 pts) MMP-2, MMP-3,
MMP-9, TIMP-1,
TIMP-2
-
  • To test if MMPs are altered in patients with HOCM and are associated with LV remodelling.

  • MMP-2 and TIMP-2 were higher in HOCM patients with EF < 25% than those with EF ≥ 25% and the control group.

  • TIMP-1 was higher in the HOCM patients than the control group.

  • MMP-3 and MMP-9 were similar among groups.

Stroud, 2005 [14] Prospective observational NRCT 34 Patient with HOCM submitted to alcohol septal ablation (18 pts) Healthy subjects (16 pts) TIMP-4 -
  • To assess if variation in plasma TIMP-4 levels occurs after alcohol-induced myocardial infarction.

  • TIMP-4 increased in HOCM patients.

  • TIMP-4 increased at 10 h post alcohol injection and decreased after 30 h.

Roldàn, 2008 [15] Prospective observational NRCT 125 Patient with HOCM (67 pts) Healthy subjects (58 pts) MMP-1, MMP-2, MMP-9, TIMP-1 NT-proBNP
  • To evaluate the correlation between MMPs and myocardial collagen turnover, fibrosis, functional status, and prognosis.

  • MMP-2 and MMP-9 were higher in HOCM patients.

  • MMP-2 was associated with dyspnoea and correlated with MMP-9 and NT-proBNP.

  • MMP-9 was associated with fibrosis.

Saura, 2009 [16] Prospective observational NRCT 73 Patient with HOCM (73 pts) - MMP-2, TIMP-1 NT-pro-BNP, C-reactive protein
  • To assess the influence of left atrial volume on exercise performance to MMP2 and TIMP-1.

  • Enlarged left atrial volume is associated with MMP-2.

  • Left atrial volume is significantly associated with TIMP-1.

Kitaoka, 2010 [17] Retrospective observational NRCT 41 Patient with HOCM (41 pts) - MMP-2, MMP-9,
TIMP-1
BNP
  • To evaluate the role of MMPs levels in the LV remodelling process;

  • To assess the MMPs as a predictor of heart failure in HOCM patients.

  • MMP-2 levels were higher in HOCM patients with severe symptoms;

  • MMP-2 and TIMP-1 levels were positively associated with LV end-systolic and left atrial dimensions, and inversely related to LV EF.

  • MMP-2 levels were positively related to BNP levels;

  • MMP-9 were not related to echocardiographic parameters and plasma BNP levels.

Kitaoka, 2011 [18] Prospective observational NRCT 16 * Patient with HOCM (16 pts) - MMP-2, MMP-9,
TIMP-1
BNP
  • To evaluate whether MMPs plasma levels were related to LV remodelling;

  • To observe whether MMPs levels were related to the deterioration in left ventricular systolic function in HOCM patients with preserved LV EF.

  • MMP-2 levels were inversely related to LV EF;

  • MMP-9 levels were inversely related to LV end-diastolic dimension and positively related to the maximum LV wall thickness.

Zachariah, 2012 [19] Prospective observational NRCT 45 Patient with HOCM (45 pts) - MMP-1, MMP-2, MMP-3, MMP-9, TIMP-1, TIMP-2, TIMP-3, TIMP-4 -
  • To evaluate the association between ventricular arrythmia and MMPs.

  • Patients with ventricular arrythmia had significantly higher MMP-3 levels than patients without arrythmia.

  • Ventricular arrythmia was independently associated with MMP-3.

Fucikova, 2016 [20] Prospective observational NRCT 30 Patient with HOCM (17 pts) Healthy subjects (17 pts) MMP-2, MMP-9, TIMP-1, TIMP-2 BNP, fibronectin
  • To assess the abundance of proteins and plasma fibronectin in HOCM patients.

  • TIMP-2 levels were higher in HOCM patients;

  • MMP2, MMP-9, and TIMP-1 were similar between groups.

Munch, 2016 [21] Retrospective observational NRCT 54 Patient with HOCM (54 pts) - MMP-1, MMP-2, MMP-3, MMP-9, TIMP-1 -
  • To evaluate if myocardial collagen turnover changes according to gender;

  • To evaluate myocardial collagen turnover proteins and cardiac events.

  • MMP-9 was associated with fibrosis and cardiac events in females;

  • Increased MMP-2 levels in females were associated with lower fibrosis;

  • MMP-3 levels were positively associated with cardiac events;

  • No association was detected for MMP-1 and TIMP-1.

Fernlund, 2017 [22] Prospective observational NRCT 105 Patient with HOCM (39 pts) Healthy subjects (66 pts) MMP-9 -
  • To evaluate whether serum biomarkers reflect myocardial remodelling in the early stage of HOCM.

  • MMP-9 levels were increased in the HOCM patients and correlated to the LV mass index.

Yang, 2019 [23] Prospective observational NRCT 52 Patient with HOCM submitted to surgical myectomy (52 pts) - MMP-2, MMP-9, TIMP-1 -
  • To assess the biomarkers of myocardial fibrosis in HOCM patients submitted to cardiac surgery.

  • TIMP-1 plasma levels were correlated to myocardial content;

  • MMP-2 and MMP-9 were not significantly correlated with those of myocardial tissues;

  • Plasma MMP-9 levels were found to be significantly related to TIMP-1 levels;

  • Plasma MMP-2 levels were positively correlated with collagen volume fraction.

Qian, 2020 [24] Prospective observational NRCT 30 Patient with HOCM submitted to percutaneous intramyocardial septal radiofrequency ablation (30 pts) - MMP-2 -
  • To assess myocardial fibrosis after percutaneous intramyocardial septal radiofrequency ablation in HOCM patients.

  • At 1-month follow-up, MMP-2 levels were lower than before the procedure.

Bi, 2021 [25] Prospective observational NRCT 55 Patient with HOCM submitted to surgical myectomy (55 pts) - MMP-2, MMP-9, TIMP-1 -
  • To demonstrate the relationship among myocardial collagen turnover proteins, microvascular remodelling, and myocardial fibrosis in HOCM patients.

  • To assess the prognostic value of collagen-related biomarkers in HOCM patients after cardiac surgery.

  • Plasma MMP-2 correlated with left atrium diameters;

  • Septal thickness was associated with the plasma MMP-9/TIMP-1 ratio, MMP-2/TIMP-1 ratio, and TIMP-1 levels;

  • LVOT pressure gradient was correlated with MMP-2/TIMP-1 ratio;

  • Microvascular density was inversely correlated with MMP-2/TIMP-1 ratio;

  • Microvascular density was higher in patients with lower MMP-2 levels;

  • MMP-9 and MMP-9/TIMP-1 were not related to microvascular density;

  • No significant correlations were found between myocardial MMPs and plasma MMPs.

* Among 16 patients, 11 patients were included in a previous study by the same group (Kitaoka 2010). Abbreviations: CK, creatine kinase; EF, ejection fraction; HOCM, hypertrophic obstructive cardiomyopathy; ICTP, collagen I carboxy-terminal telopeptide; LV, left ventricle; MI, myocardial infarction; MMP, metalloproteinase; NRCT, not randomized controlled trial; NT-proBNP, N-terminal pro B-type natriuretic peptide; PICP, procollagen type I carboxy-terminal propeptide; PINP, procollagen type I amino-terminal propeptide; RCT, randomized controlled trial; TIMP, tissue inhibitors of metalloproteinases.